Lung transplant complications: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - "==Diagnosis==" to "==Evaluation==") |
ClaireLewis (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*Can transplant single lung, bilateral lungs, or heart-lungs | |||
*Indications: [[cystic fibrosis]], [[COPD]], idiopathic [[pulmonary fibrosis]] > alpha-1 antitrypsin deficiency, primary pulmonary hypertension, bronchiectasis, [[sarcoidosis]] | |||
*Lung is denervated | |||
**regulation of breathing is not lost, as it is through chest wall efferents | |||
**cough response lost below anastomosis | |||
**should have normal ABG (unless patient reliant on hypoxic respiratory drive), exercise response, and bronchomotor tone | |||
{{Immunosuppressant medication complications}} | {{Immunosuppressant medication complications}} | ||
==Clinical Features== | ==Clinical Features/Differential Diagnosis== | ||
*Signs/symptoms of infection | |||
*[[Fever]], [[cough]], worsening [[SOB]], hypoxia, tachypnea | |||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
===Infection=== | |||
*Bronchitis, [[Pneumonia]] (common) | |||
**usually bacterial early in course | |||
**MRSA and [[pseudomonas]] common | |||
**Fungi, protazoa, CMV more common >6 weeks post-op | |||
*Extra-pulmonary infections (may be severe or opportunistic due to immunosuppression) | |||
===Medication adverse effects=== | |||
*Prednisone | |||
**Hyperglycemia, psychiatric symptoms, poor wound healing, edema, hypertension | |||
*Tacrolimus, cyclosporine | |||
**Neurotoxicity, tremor, hyperkalemia, nephrotoxicity, hypertension, hyperglycemia, gout | |||
*Mycophenolate | |||
**Cytopenias, GI distress | |||
*Azathioprine | |||
**Cytopenias, pancreatitis, hepatitis | |||
===Airway complications=== | |||
*Anastomotic bronchial necrosis, dehiscence, or stenosis | |||
**bronchial vasculature is disrupted during procedure, ergo: | |||
***donor bronchus reliant on retrograde pulmonary circulation for perfusion | |||
***anastomoses vulnerable to ischemia | |||
**mild cases may be asymptomatic | |||
**may lead to worsening respiratory symptoms, [[pneumothorax]], [[pneumomediastinum]], focal infections/abscess | |||
*Occlusive granulation tissue | |||
**Asymptomatic, or worsening cough, wheezing, post-obstructive pneumonia | |||
*bronchial/tracheal stenosis, tracheobronchomalacia | |||
**cough, dyspnea, difficulty clearing respiratory secretions, recurrent infections, wheezing, stridor | |||
*bronchopleural, bronchomediastinal, or bronchovascular fisulae | |||
**can cause [[pneumothorax]], [[hypotension]], [[mediastinitis]], [[pneumomediastinum]], [[respiratory distress]] | |||
*Pulmonary vasculature problems | |||
**Pulmonary artery stricture--> hypoxia | |||
**Pulmonary venous anastomoses: vulnerable to kinking, [[pulmonary embolism]], and thromboses--> [[pulmonary edema]] | |||
*Rejection | |||
**Acute/cellular rejection: clinically silent or nonspecific respiratory symptoms | |||
**Chronic rejection (bronchiolitis obliterans): leads to airflow limitation | |||
==Evaluation== | ==Evaluation== | ||
Revision as of 23:18, 28 September 2016
Background
- Can transplant single lung, bilateral lungs, or heart-lungs
- Indications: cystic fibrosis, COPD, idiopathic pulmonary fibrosis > alpha-1 antitrypsin deficiency, primary pulmonary hypertension, bronchiectasis, sarcoidosis
- Lung is denervated
- regulation of breathing is not lost, as it is through chest wall efferents
- cough response lost below anastomosis
- should have normal ABG (unless patient reliant on hypoxic respiratory drive), exercise response, and bronchomotor tone
Immunosuppressant Medications
- Balance between immune suppression, rejection and susceptibility to infection
- Typical regimen includes: calcineurin inhibitor + antimetabolite + steroid
- Calcineurin inhibitor
- Steroids
- +/- Antimetabolite
Clinical Features/Differential Diagnosis
Differential Diagnosis
Infection
- Bronchitis, Pneumonia (common)
- usually bacterial early in course
- MRSA and pseudomonas common
- Fungi, protazoa, CMV more common >6 weeks post-op
- Extra-pulmonary infections (may be severe or opportunistic due to immunosuppression)
Medication adverse effects
- Prednisone
- Hyperglycemia, psychiatric symptoms, poor wound healing, edema, hypertension
- Tacrolimus, cyclosporine
- Neurotoxicity, tremor, hyperkalemia, nephrotoxicity, hypertension, hyperglycemia, gout
- Mycophenolate
- Cytopenias, GI distress
- Azathioprine
- Cytopenias, pancreatitis, hepatitis
Airway complications
- Anastomotic bronchial necrosis, dehiscence, or stenosis
- bronchial vasculature is disrupted during procedure, ergo:
- donor bronchus reliant on retrograde pulmonary circulation for perfusion
- anastomoses vulnerable to ischemia
- mild cases may be asymptomatic
- may lead to worsening respiratory symptoms, pneumothorax, pneumomediastinum, focal infections/abscess
- bronchial vasculature is disrupted during procedure, ergo:
- Occlusive granulation tissue
- Asymptomatic, or worsening cough, wheezing, post-obstructive pneumonia
- bronchial/tracheal stenosis, tracheobronchomalacia
- cough, dyspnea, difficulty clearing respiratory secretions, recurrent infections, wheezing, stridor
- bronchopleural, bronchomediastinal, or bronchovascular fisulae
- Pulmonary vasculature problems
- Pulmonary artery stricture--> hypoxia
- Pulmonary venous anastomoses: vulnerable to kinking, pulmonary embolism, and thromboses--> pulmonary edema
- Rejection
- Acute/cellular rejection: clinically silent or nonspecific respiratory symptoms
- Chronic rejection (bronchiolitis obliterans): leads to airflow limitation
